Press Releases

Takeda Pharmaceutical Company Limited announced that the EC has granted conditional marketing authorization for NINLAROTM （ixazomib）capsules, indicated in combination with lenalidomide and dexamethasone for adult patients with multiple myeloma who have received at least one prior therapy. ...

Over 90 senior leaders in parallel trade will meet in London in February 2017 to discuss upcoming trends and share best practices.With Brexit and the new EU Falsified Medicine Directive, what does the future hold for parallel trade? ...

The Indian pharmaceutical industry saw the launch of the grand 10th anniversary edition of UBM India’s signature event, CPhI & P-MEC India 2016, one of the world’s leading pharma networking expos.  To celebrate the landmark, this...

Materials scientists can now gain valuable insight into the relationships between a material’s structure at the microscopic level and its bulk properties using a new multi-scale imaging solution that is designed to provide large-scale, high-fidelity three-dimensional (3D) images of...

Novo Nordisk announced that the US FDA has approved the NDA for Xultophy® 100/3.6.Xultophy® 100/3.6 is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus inadequately controlled on basal insulin...

GSK  announced it has received approval from the US Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research expanding the indication for FluLaval® Quadrivalent (Influenza Vaccine) to include use in children 6 months and older. ...

UBM India, India's leading exhibition organizer, launched the India Pharma Week, a bouquet of over 10 trend-setting activities across the city of Mumbai, to mark the special 10th anniversary of CPhI & P-MEC India 2016, its flagship event and...